Celldex Therapeutics | CLDX - Net Income

Stock Price
30.03
Daily Change
1.49 5.22%
Monthly
30.45%
Yearly
51.06%
Q1 Forecast
28.62

Celldex Therapeutics reported $-81.32M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Agenus USD -10.63M 74.49M Dec/2025
Amgen USD 1.33B 1.88B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Celldex Therapeutics USD -81.32M 14.27M Dec/2025
Glaxosmithkline GBP 846.06M 1.87B Dec/2025
Nektar Therapeutics USD -37.06M 15.31M Sep/2024
Northwest Biotherapeutics USD -19.37M 1.5M Sep/2024
Pfizer USD -1.65B 5.19B Dec/2025
Rigel Pharmaceuticals USD 12.42M 13.45M Sep/2024
Roche Holding CHF 5.47B 1.76B Dec/2025